Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
Meeting report with video, highlights and slides of PACE-CME symposium held during ERA EDTA 2017 in Madrid on the potential role of epigenetics in patients with CKD, CVD and Diabetes
Episodes 1-3 of 3
- Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?Molecular mechanisms involved in the beneficial effect of BET inhibition in experimental renal disease
- Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?BET inhibition in renal and cardiovascular disease: What is the clinical roadmap?
Kamyar Kalantar-Zade, MD
- Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
Luis M Ruilope, MD
